Pachyosteosclerosis

Pachyosteosclerosis is a skeletal condition characterized by thickened bones (pachyostosis) and increased bone density (osteosclerosis), producing abnormally heavy, dense bones with reduced marrow spaces. It can be generalized or focal, affecting the skull, spine, and long bones.

Cause and mechanism: The condition reflects an imbalance of bone remodeling, with increased osteoblastic activity or decreased resorption leading to excessive deposition and mineralization. This may result in cortical thickening and narrowed marrow spaces, sometimes with reduced fracture resistance.

Etiology: Pachyosteosclerosis occurs in hereditary sclerosing bone dysplasias, where specific gene mutations have been identified, and in acquired states such as chronic fluoride exposure (fluorosis). The exact genetic architecture varies by condition.

Clinical features: Symptoms range from none to bone pain, deformities, limited mobility, and nerve compression when cranial or spinal regions are involved. Dental anomalies and facial asymmetry may also occur.

Diagnosis and management: Diagnosis relies on imaging showing diffuse or focal bone densification with thickened cortex and reduced medullary space; CT can quantify density. Histology shows dense lamellar bone. Treatment is supportive, addressing symptoms and complications; avoid high-risk activities; surgical decompression is considered for nerve entrapment when indicated.

Prognosis: Prognosis varies with the extent and distribution of involvement.